Publicaciones (43) Publicaciones de MARÍA GLORIA MOLERO MARTÍN-PORTUGUÉS

2024

  1. Unravelling the Role of Candida albicans Prn1 in the Oxidative Stress Response through a Proteomics Approach

    Antioxidants, Vol. 13, Núm. 5

2021

  1. A wide-ranging Pseudomonas aeruginosa PeptideAtlas build: A useful proteomic resource for a versatile pathogen

    Journal of Proteomics, Vol. 239

2019

  1. Interacción microorganismo hospedador. Proyecto Proteoma Humano

    SEM@foro, Núm. 67, pp. 34-36

2017

  1. Candida albicans Modifies the Protein Composition and Size Distribution of THP-1 Macrophage-Derived Extracellular Vesicles

    Journal of Proteome Research, Vol. 16, Núm. 1, pp. 87-105

2016

  1. Apoptosis of Candida albicans during the interaction with murine macrophages: Proteomics and cell-death marker monitoring

    Journal of Proteome Research, Vol. 15, Núm. 5, pp. 1418-1434

  2. The fungal resistome: A risk and an opportunity for the development of novel antifungal therapies

    Future Medicinal Chemistry, Vol. 8, Núm. 12, pp. 1503-1520

2015

  1. Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections

    International Journal of Pharmaceutics, Vol. 494, Núm. 1, pp. 17-22

2014

  1. New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp

    International Journal of Pharmaceutics, Vol. 473, Núm. 1-2, pp. 148-157

  2. Proteomic characterization of human proinflammatory M1 and anti-inflammatory M2 macrophages and their response to Candida albicans

    Proteomics, Vol. 14, Núm. 12, pp. 1503-1518

2013

  1. Candida albicans induces pro-inflammatory and anti-apoptotic signals in macrophages as revealed by quantitative proteomics and phosphoproteomics

    Journal of Proteomics, Vol. 91, pp. 106-135

  2. Host-pathogen interaction: Insights from proteomics

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 9, pp. 36-36

2012

  1. A novel formulation of solubilised amphotericin B designed for ophthalmic use

    International Journal of Pharmaceutics, Vol. 437, Núm. 1-2, pp. 80-82

  2. Sub-proteomic study on macrophage response to Candida albicans unravels new proteins involved in the host defense against the fungus

    Journal of Proteomics, Vol. 75, Núm. 15, pp. 4734-4746

2011

  1. In vivo virulence of commercial Saccharomyces cerevisiae strains with pathogenicity-associated phenotypical traits

    International Journal of Food Microbiology, Vol. 144, Núm. 3, pp. 393-399

  2. Proteomic and phosphoproteomic study of the macrophage response to candida albicans using silac and simac

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 7, pp. 57-57

2010

  1. Análisis mediante 2D-DIGE de la interacción con sangre de una cepa de Saccharomyces cerevisiaea potencialmente patógena aislada de suplementos dietéticos

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 5, pp. 123-124

  2. Expresión diferencial de proteínas del citoesqueleto del macrófago tras la interacción con Candida albicans: Problemas en la normalización de las muestras

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 5, pp. 135-136

  3. Gel and gel-free proteomics to identify Saccharomyces cerevisiae cell surface proteins

    Journal of Proteomics, Vol. 73, Núm. 6, pp. 1183-1195

2009

  1. 2D-DIGE analysis of potentially pathogen saccharomyces sereviciae strains isolated from dietary supplements after incubation in human blood

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 3, pp. 175-175

  2. Diving into the mouse macrophage cytoskeletal proteome upon the interaction with candida albicans

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 3, pp. 165-165